Mesenchymal stem cell (MSC) transplantation by intramyocardial injection has been proposed as a promising therapy strategy for cardiac repair after myocardium infarction. However, low retention and survival of grafted MSCs hinder its further application. In this study, copolymer with N-isopropylacrylamide/acrylic acid/2-hydroxylethyl methacrylate-poly(ɛ-caprolactone) ratio of 88:9.6:2.4 was bioconjugated with type I collagen to construct a novel injectable thermosensitive hydrogel. The injectable and biocompatible hydrogel-mediated MSC transplantation could enhance the grafted cell survival in the myocardium, which contributed to the increased neovascularization, decreased interstitial fibrosis, and ultimately improved heart function to a significantly greater degree than regular MSC transplantation. We suggest that this novel hydrogel has the potential for future stem cell transplantation.
HouDYoussefEABrintonTJZhangPRogersPPriceETYeungACJohnstoneBHYockPGMarchKL. Radiolabeled cell distribution after intramyocardial, intracoronary, and interstitial retrograde coronary venous delivery: implications for current clinical trials. Circulation2005; 112: I150–156.
5.
HofmannMWollertKCMeyerGPMenkeAArsenievLHertensteinBGanserAKnappWHDrexlerH. Monitoring of bone marrow cell homing into the infarcted human myocardium. Circulation2005; 111: 2198–202.
YeZZhouYCaiHTanW. Myocardial regeneration: roles of stem cells and hydrogels. Adv Drug Deliv Rev2011; 63: 688–97.
9.
MartensTPGodierAFParksJJWanLQKoeckertMSEngGMHudsonBIShermanWVunjak-NovakovicG. Percutaneous cell delivery into the heart using hydrogels polymerizing in situ. Cell Transplant2009; 18: 297–304.
10.
DuboisGSegersVFBellamyVSabbahLPeyrardSBrunevalPHagègeAALeeRTMenaschéP. Self-assembling peptide nano- fibers and skeletal myoblast transplantation in infarcted myocardium. J Biomed Mater Res B Appl Biomater2008; 87: 222–8.
11.
Van TommeSRStormGHenninkWE. In situ gelling hydrogels for pharmaceutical and biomedical applications. Int J Pharm2008; 355: 1–18.
12.
SolisFJWeiss-MalikRVernonB. Local monomer activation model for phase behavior and calorimetric properties of LCST gel-forming polymers. Macromolecules2005; 38: 4456–64.
13.
LianSXiaoYBianQXiaYGuoCWangSLangM. Injectable hydrogel as stem cell scaffolds from the thermosensitive terpolymer of NIPAAm/AAc/HEMAPCL. Int J Nanomedicine2012; 7: 4893–905.
14.
ZhuKGuoCXiaYLaiHYangWWangYSongDWangC. Transplantation of novel vascular endothelial growth factor gene delivery system manipulated skeletal myoblasts promote myocardial repair. Int J Cardiol2013; 168: 2622–31.
15.
JohnsonTDChristmanKL. Injectable hydrogel therapies and their delivery strategies for treating myocardial infarction. Expert Opin Drug Deliv2013; 10: 59–72.
16.
DaiWZhangYDuZRuMLangM. The pH-induced thermosensitive poly (NIPAAm-co-AAc-co-HEMA)-g-PCL micelles used as a drug carrier. J Mater Sci Mater Med2010; 21: 1881–90.
17.
IbusukiSHalbesmaGJRandolphMARedmondRWKochevarIEGillTJ. Photochemically cross-linked collagen gels as three-dimensional scaffolds for tissue engineering. Tissue Eng2007; 13: 1995–2001.
18.
ChenRNWangGMChenCHHoHOSheuMT. Development of n,o-(carboxymethyl)chitosan/collagen matrixes as a wound dressing. Biomacromolecules2006; 7: 1058–64.
19.
GrossmanPMHanZPalasisMBarryJJLedermanRJ. Incomplete retention after direct myocardial injection. Catheter Cardiovasc Interv2002; 55: 392–7.
20.
DowJSimkhovichBZKedesLKlonerRA. Washout of transplanted cells from the heart: a potential new hurdle for cell transplantation therapy. Cardiovasc Res2005; 67: 301–7.
21.
MaXZhangQYangXTianJ. Development of new technologies for stem cell research. J Biomed Biotechnol2012; 2012: 741416–741416.
22.
KuciaMRecaRMiekusKWanzeckJWojakowskiWJanowska-WieczorekARatajczakJRatajczakMZ. Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: pivotal role of the sdf-1-cxcr4 axis. Stem Cells2005; 23: 879–94.
23.
KimSWLeeDWYuLHZhangHZKimCEKimJMParkTHChaKSSeoSYRohMSLeeKCJungJSKimMH. Mesenchymal stem cells overexpressing GCP-2 improve heart function through enhanced angiogenic properties in a myocardial infarction model. Cardiovasc Res2012; 95: 495–506.
24.
ChenDYWeiHJLinWWLinKJHuangCCWuCTHwangSMChangYSungHW. Intramuscular delivery of 3D aggregates of HUVECs and cbMSCs for cellular cardiomyoplasty in rats with myocardial infarction. J Control Release2013; 172: 419–25.
25.
TianTChenBXiaoYYangKZhouX. Intramyocardial autologous bone marrow cell transplantation for ischemic heart disease: a systematic review and meta-analysis of randomized controlled trials. Atherosclerosis2014; 233: 485–92.
